DL-2-Methylserine is a non-proteinogenic, serine-derived amino acid featuring a side chain analogous to serine but bearing an additional methyl substituent at the alpha position (2-methyl substitution) while retaining the hydroxymethyl functionality characteristic of the serine family. The molecule contains a free amino group and a free carboxyl group, and the "DL" designation indicates a racemic mixture of stereoisomers at the stereogenic center, which can influence conformational preferences and incorporation behavior in peptide-like structures. In chemical biology and peptide chemistry, it is employed as a modified amino acid building block for structure-activity studies, synthetic analog generation, and analytical method development where altered steric and hydrogen-bonding properties relative to serine are of interest.
CAT No: CP08401
CAS No:5424-29-3
Synonyms/Alias:2-Methylserine;5424-29-3;alpha-Methyl-DL-serine;2-amino-3-hydroxy-2-methylpropanoic acid;DL-2-Methylserine;3398-40-1;2-Methyl-DL-serine;.alpha.-Methyl-DL-serine;Serine, 2-methyl-, DL-;DL-Serine, 2-methyl-;alpha-Methylserine;dl-2-methylserine hydrate;CZ8HQ2F53F;H-2-Me-DL-Ser-OH;alpha-Methyl-D,L-serine;DL-.alpha.-Methylserine;EINECS 226-565-5;MFCD00021680;NSC 11203;NSC 12135;NSC-11203;NSC-12135;NSC-163492;2-Amino-3-hydroxy-2-methylpropionic acid;CHEBI:17799;CHEBI:134206;DTXSID001346506;(R,S)-2-Amino-3-hydroxy-2-methylpropionic acid hydrate;NSC 163492;DTXSID80937461;a-methylserine;MFCD00145210;MFCD00145243;rac-alpha-MeSer;2-Methylserine #;rac-2-methylserine;H-a-Me-Ser-OH;?-Methyl-D,L-serine;H-a-Me-D-Ser-OH;UNII-CZ8HQ2F53F;.ALPHA.-METHYLSERINE;SCHEMBL22926;CHEMBL539702;DTXCID60964038;DTXCID901366024;Serine, 2-methyl-, DL-(8CI);NSC11203;NSC12135;NSC163492;AKOS006221903;CS-W013589;HY-W012873;FM166762;PD196581;SY047210;SY047311;SY047312;2-amino-3-hydroxy-2-methyl-propionic acid;Propanoic acid, 2-amino-2-methyl-3-hydroxy-;rac-2-amino-2-methyl-3-hydroxypropanoic acid;rac-2-amino-2-methyl-3-hydroxypropionic acid;rac-2-amino-3-hydroxy-2-methylpropanoic acid;rac-2-amino-3-hydroxy-2-methylpropionic acid;EN300-175656;F70028;A1-51401;Q27102625;9A30BC2E-CA96-44A4-8E4B-097E9C16DDB9;226-565-5;
DL-2-Methylserine is a serine-derived amino acid analog bearing a chiral 2-methyl substituent on the α-carbon and a side-chain hydroxymethyl group, giving it the general amino acid functionality of an amino group and a carboxylic acid (or corresponding ester/amide forms depending on derivatization). The presence of the additional methyl substituent increases steric demand around the stereocenter and can influence conformational preferences relative to serine, while the hydroxyl-bearing side chain enables hydrogen-bonding and straightforward functional group transformations. As a DL mixture, the compound contains both enantiomers, which is relevant for studies requiring racemic incorporation or for downstream resolution strategies to access stereodefined 2-methylserine building blocks. The amino acid framework supports standard peptide-coupling chemistries after appropriate protection of the amine and carboxyl functionality, making it a practical intermediate for amino acid derivatization and peptide science.
1. Peptide Synthesis
DL-2-Methylserine is applied in peptide building block preparation where α-amino acid coupling to form amide bonds is required, and its serine-like side-chain hydroxyl can be selectively protected to control chemoselectivity during stepwise synthesis. The amino and carboxyl functionalities allow conversion into N-protected amino acid derivatives and C-terminal activated forms, supporting peptide coupling strategies compatible with common peptide coupling reagents. The added 2-methyl stereocenter can be incorporated into peptide backbones to probe steric effects on conformation and intramolecular hydrogen bonding patterns involving the side-chain hydroxyl. Downstream, protected DL-2-methylserine residues can be used to generate peptide analogs for biochemical research and SAR studies where racemic incorporation is acceptable or where later enantiomer separation is planned.
2. Side-Chain Functionalization
DL-2-Methylserine is used for amino acid derivatization workflows targeting side-chain hydroxyl chemistry, including etherification, ester formation, and conversion to leaving groups for further substitution. The hydroxymethyl group can be protected and deprotected to enable controlled introduction of polar or hydrophobic substituents, while maintaining the amino acid core for subsequent coupling or analytical derivatization. The α-methyl substituent can modulate reactivity by affecting local sterics around the functionalized side chain, which can be relevant when designing fragments for peptidomimetic construction. Resulting derivatives serve as intermediates for generating functional amino acid analogs, solubility-tuned peptide fragments, and chemically defined standards for monitoring hydroxyl-based transformations in synthetic organic chemistry.
3. Chiral Building Block Development
DL-2-Methylserine is suitable for chiral synthesis and stereochemical studies because the racemic mixture can be resolved or converted into diastereomeric derivatives for enantiomer discrimination. The single stereocenter at C-2 provides a clear handle for downstream stereochemical control, enabling preparation of stereodefined 2-methylserine derivatives used in enantioselective peptide construction and stereochemical SAR investigations. N- and O-protection strategies can be employed to stabilize the amino acid during resolution, activation, and peptide coupling, while minimizing epimerization risk under appropriate conditions. Enantiopure downstream products can then be incorporated into peptides and peptidomimetics to support structure-function mapping where stereochemistry at the α-carbon is a key design variable.
4. Chemical Biology Research
DL-2-Methylserine is applied in chemical biology research as a serine analog for introducing hydroxyl-bearing residues with altered steric profile into peptide scaffolds and protein-interaction probes. The amino acid backbone supports incorporation into modified peptides that can participate in hydrogen-bonding networks and side-chain recognition motifs, while the 2-methyl substitution can shift local geometry and affect binding conformations. The side-chain hydroxyl enables attachment of tags or reactive handles after controlled protection, supporting downstream conjugation to affinity probes or labeling reagents. Generated peptide-based tools can be used to interrogate substrate tolerance, binding preferences, and recognition patterns in biochemical assays where an amino acid analog with a hydroxymethyl group is required.
5. Pharmaceutical Intermediate Preparation
DL-2-Methylserine is relevant to pharmaceutical intermediate preparation and process chemistry as a chiral amino acid precursor platform that can be transformed into protected amino acid derivatives for controlled manufacturing routes. The amino acid's functional groups support conversion into N-protected intermediates and activated carboxyl derivatives, enabling incorporation into larger fragments used in peptidic or peptidomimetic synthesis. The hydroxyl-bearing side chain can be managed through protection-group selection to ensure compatibility with multi-step coupling and deprotection sequences, while the α-methyl stereocenter provides a structural motif that can be retained or resolved depending on target specifications. Downstream, stereodefined or racemic 2-methylserine-containing intermediates can be used to build well-defined molecular entities for fine chemical synthesis and applied product development workflows.
2. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
3. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
4. TMEM16F and dynamins control expansive plasma membrane reservoirs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.